Answers are grounded in this paper and cite their sources.
BACKGROUND AND OBJECTIVES: Anemia has been associated with idiopathic intracranial hypertension (IIH) in small studies, but whether severity modulates IIH risk remains unclear. This study evaluated the hazard of incident IIH after mild, moderate, and severe anemia in young adults. METHODS: Using the TriNetX Research Network (111) health care organizations), adults aged 18-50 years with persistent anemia (≥2 hemoglobin values) were stratified as mild (11.0-12.9 g/dL), moderate (8.0-10.9 g/dL), or severe (<8.0 g/dL) and matched 1:1 to controls (Hb ≥ 13.0 g/dL) by propensity score matching on demographics, body mass index, comorbidities, and socioeconomic factors. The primary outcome was incident IIH; Cox proportional hazards models estimated hazard ratios (HRs) at 6 months, 1 year, and 3 years. Sensitivity analyses applied the World Health Organization (WHO) women's mild threshold and compared patients with vs without iron supplementation. RESULTS: After matching, 1,240,670 mild anemia patients (mean age 29.0 ± 8.7 years, 83.4% female), 666,515 moderate (29.7 ± 8.1, 86.3% female), and 114,785 severe (31.0 ± 8.9, 75.4% female) were compared with equal-sized control cohorts. Hazard of incident IIH was elevated at every severity and time interval. At 6 months, HRs were 1.45 (95% CI 1.29-1.63), 1.61 (1.39-1.86), and 2.53 (1.82-3.52) for mild, moderate, and severe anemia. At 1 year, HRs were 1.35 (1.22-1.49), 1.33 (1.17-1.51), and 1.94 (1.46-2.58). At 3 years, HRs were 1.17 (1.08-1.26), 1.15 (1.04-1.27), and 1.40 (1.11-1.76); all estimates remained significantly elevated, although CIs overlapped across severity bands. The WHO women's threshold sensitivity yielded concordant, modestly stronger estimates (6 months: HR 1.99 [1.73-2.30]; 3 years: 1.43 [1.31-1.58]). Iron supplementation was associated with reduced IIH hazard (HR 0.75, 95% CI 0.62-0.93; n = 340,660 per group). DISCUSSION: Anemia is associated with elevated hazard of incident IIH in young adults across all severity bands. Point estimates were higher with greater anemia severity and at earlier follow-up, but CIs overlapped across severity bands, so a severity gradient could not be established. Iron supplementation was associated with reduced hazard. Findings are limited by observational design, administrative case identification, and low absolute incidence; anemia represents a potentially modifiable factor warranting evaluation in patients with papilledema.
No takes yet. Share an insight, caveat, or question.
Butt et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: